Medtronic plc (MDT) stock had a bullish inflow of $8.16 million worth of trades on uptick and an outflow of $1.79 million in downticks on Wednesday. The total uptick to downtick ratio stood at 4.56. The net money flow into the stock was $6.37 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $6.44 million. $6.44 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. However, Medtronic plc (MDT) stock traded down $0.03 , and reached $88.35, a drop of -0.03% over the previous day. On a weekly basis, the stock is -0.01%, over the previous weeks close.
Also, SunTrust Robinson Humphrey maintains their rating on the shares of Medtronic plc (NYSE:MDT). The current rating of the shares is Buy. Equity Analysts at the Firm raises the price target to $98 per share from $93 per share. The rating by the firm was issued on June 13, 2016.
Medtronic plc (NYSE:MDT): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $87.86 and $87.86 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $89.01. The buying momentum continued till the end and the stock did not give up its gains. It closed at $88.75, notching a gain of 0.42% for the day. The total traded volume was 2,988,815 . The stock had closed at $88.38 on the previous day.
The stock has recorded a 20-day Moving Average of 2.62% and the 50-Day Moving Average is 5.9%. In a related news, The Securities and Exchange Commission has divulged that Ellis Gary Lee, officer (EVP & Global Ops and IT) of Medtronic Plc, had unloaded 35,495 shares at an average price of $88.64 in a transaction dated on July 13, 2016. The total value of the transaction was worth $3,146,277.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.